Table 5.
Category | First site of recurrence (%) | p value | |||
---|---|---|---|---|---|
Soft tissue | Bone | Viscera | Brain | ||
QpCR | |||||
pCR | 3 (50.0) | 0 | 3 (50.0) | 0 | 0.26 |
Non-pCR | 17 (27.9) | 9 (14.8) | 27 (44.2) | 8 (13.1) | |
CpCR | |||||
pCR | 3 (50.0) | 0 | 3 (50.0) | 0 | 0.26 |
Non-pCR | 17 (27.9) | 9 (14.8) | 27 (44.2) | 8 (13.1) | |
CpCRbn | |||||
pCR | 2 (40.0) | 0 | 3 (60.0) | 0 | 0.38 |
Non-pCR | 18 (29.0) | 9 (14.5) | 27 (43.6) | 8 (12.9) | |
SpCR | |||||
pCR | 2 (50.0) | 0 | 2 (50.0) | 0 | 0.46 |
Non-pCR | 18 (28.6) | 9 (14.3) | 28 (44.4) | 8 (12.7) | |
SpCRbn | |||||
pCR | 1 (33.3) | 0 | 2 (66.7) | 0 | 0.60 |
Non-pCR | 19 (29.7) | 9 (14.0) | 28 (43.8) | 8 (12.5) | |
JBCS | |||||
Grade 3 | 3 (50.0) | 0 | 3 (50.0) | 0 | 0.26 |
Grade 2b | 0 | 0 | 0 | 0 | |
Grade 0–2a | 17 (27.9) | 9 (14.8) | 27 (44.2) | 8 (13.1) | |
Subtype | |||||
Luminal | 10 (27.8) | 7 (19.4) | 17 (47.2) | 2 (5.6) | 0.13 |
Luminal/Her2-positive | 0 | 0 | 5 (83.3) | 1 (16.7) | |
Her2-positive | 2 (40.0) | 0 | 2 (40.0) | 1 (20.0) | |
Triple negative | 8 (40.0) | 2 (10.0) | 6 (30.0) | 4 (20.0) |
JBCS Japanese Breast Cancer Society